Disulfidptosis as a key regulator of glioblastoma progression and immune cell impairment
BackgroundGlioblastoma, associated with poor prognosis and impaired immune function, shows potential interactions between newly identified disulfidptosis mechanisms and T cell exhaustion, yet these remain understudied.MethodsKey genes were identified using Lasso regression, followed by multivariate...
Saved in:
Main Authors: | Yifu Shu, Jing Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1526296/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Escherichia coli combination with PD-1 blockade synergistically enhances immunotherapy in glioblastoma multiforme by regulating the immune cells
by: Guochen Li, et al.
Published: (2025-02-01) -
Overcoming immune evasion with innovative multi-target approaches for glioblastoma
by: Hai Su, et al.
Published: (2025-01-01) -
Expression and clinical significance of disulfidptosis-related LncRNA in gastric cancer
by: CHU Yudan, SUN Haidong, CUI Ran, ZHENG Hong
Published: (2024-09-01) -
Disulfidptosis-related immune patterns predict prognosis and characterize the tumor microenvironment in oral squamous cell carcinoma
by: Xuechen Wu, et al.
Published: (2025-02-01) -
Pan-Cancer Analysis of Disulfidptosis-Related Genes Affecting Prognosis and Tumor Microenvironment
by: Jingyang SUN, et al.
Published: (2025-01-01)